x
ServiziMenu principaleHome

Curriculum

 

Seminar 1 

Module 1 

Module 2

Seminar 2

Module 3

Module 4

Seminar 3

Total 

Timeline

 2020
15-18 April

2020
mid Apr/ mid Jul

2020
mid Jul/ mid Oct

2020
18-22 September

2020-21
Nov/mid Jan
20219

2021
Mid Jan/Mar

2021
May

12 months 

Content

Reading materials
+
CAS LC course
+
ELCC

 

Epidemiology,
prevention,
biology and
pathology of lung
cancer and
other thoracic malignancies

 Principles of
lung cancer research



Reading materials
+
CAS LC course
+
Selected sessions
of the ESMO Congress

Principles of
NSCLC diagnosis
and treatment

Principles of
treatment
of SCLC, MPM,
thymoma &
thymic cancer

Pre-seminar
preparation of
a clinical case presentation
+
CAS LC course
including
final exam

 

Workload

25 hrs
in-person
+ 5 hrs reading
materials

26 units
78 hrs
Distance learning
+ test

24 units
72 hrs
Distance learning
+ test

25 hrs in-person
+ 5 hrs reading materials

30 units
90 hrs
Distance learning
+ test

30 units
90 hrs
Distance learning
+ test

25 hrs
in-person
+ 5 hrs
preparation
of a clinical
case
incl. certificate exam

90 hrs
seminars +
330 hrs
distance l.
420 hrs

Credits

1 ECTS 

5 ECTS

1 ECTS 

3 ECTS

3 ECTS

1 ECTS

14ECTS 


CAS LC:
separate and specific seminar for Certificate of Advanced Studies in Lung Cancer participants

ELCC: Join the European Lung Cancer Conference, Geneva - ESMO: Join the European Society for Medical Oncology Congress (selected sessions)

The extensiveness of the Module’s programme is expressed in Units.
1 Unit equals to 3 hours of workload, consisting of a 30-minute lecture and 2,5 hours of additional reading.
For instance: 2 Units = 6 hours of workload = 60-minute lecture + 5 hours of additional reading.
The Modules end with a multiple-choice test.

The extensiveness of the Seminar’s programme is 30 hours, with approximately 25 hours of attendance and 5 hours of additional reading or of the preparation of a clinical case presentation.
The Seminars are assessed within the final multiple-choice exam.

 

 Seminar 1

 CAS Lung Cancer programme +
 Participation in the European Lung Cancer Conference (ELCC)

 

 Date and
 place
 15-18 April 2020, Geneva, Switzerland

 

 ECTS
 1  
 Assessment  Included in final exam  
 Workload
 hours   
 

30

  Programme to be announced  
 
 Module 1  Epidemiology, prevention, biology and pathology of lung cancer and other thoracic 
 malignancies
 
Scientific Directors: Keith Kerr and Alex Soltermann
 
 Period  Mid-April / mid-July 2020  
 ECTS  Mod 1 + 2 = 5 ECTS  
 Assessment  Test (52 multiple-choice questions)

 

 Workload
 hours
 78  
 Units   26
   - Epidemiology [Paolo Boffetta] 2
 - Risk factors and environmental exposure [Jonathan Samet] 2
 - Primary prevention [Emily Stone] 2
 - Screening [John Field] 2
 - The Cancer Genome Atlas in lung cancer [Ramaswamy Govindan] 2
 - Immuno-oncology from a biological perspective: Biological principles of tumour immunology
   [Maries van den Broek]
2
 - Immuno-oncology from a biological perspective: Biomarkers from immune-oncology [Ming S. Tsao] 2
 - Molecular classification of lung cancer [Martin L. Sos] 2
 - Methods of molecular diagnostics: Tissue based [Erik Thunnissen] 2
 - Methods of molecular diagnostics: Nucleic-acid based [Nicola Normanno] 2
 - Pathological classification of lung cancer: NSCLC & SCLC [Sylvie Lantuejoul] 2
 - Epidemiology and pathological classification of rare thoracic malignancies [Andrew Nicholson] 2
 - Cancer survivorship [Dany Bell] 2
 
 Module 2  Principles of lung cancer research
 
Scientific Directors: Christian Britschgi and Solange Peters
 
 Period  Mid-July / mid-October 2020  
 ECTS  Mod 1 + 2 = 5 ECTS  
 Assessment  Test (48 multiple-choice questions)  
 Workload
 hours
 72  
 Units   24
   - Principles of basic research [Anton Berns] 2
 - Principles of translational research [Christian Britschgi] 2
 - Biobanking [Mitchell Levesque] 2
 - Principles of phase 1, 2, 3 clinical trials [Uriana Dafni] 2
 - Clinical trial databases and registries [Uriana Dafni] 2
 - Design and conduct of clinical trials [Anouk Neven] 2
 - Good clinical practice [Anita Hiltbrunner] 2
 - Valid end-points of clinical trials [Enriqueta Felip] 2
 - Interpretation of clinical trial results [Jean-Paul Sculier] 2
 - ESMO magnitude of clinical benefit scale [Uriana Dafni] 2
 - Legal requirements and frameworks for pre-clinical and clinical reserach [Anastassia Negrouk] 2
 - Lung cancer research organisations and societies : ETOP, EORTC [Rolf Stahel] 2
  
 Seminar 2  CAS Lung Cancer programme +
 Participation in selected sessions of the ESMO Congress
 
 Date and
 place
 18-22 September 2020, Madrid, Spain  
 ECTS  1  
 Assessment
 Included in final exam  
 Workload
 hours
  30
  Programme to be announced  
  
 Module 3
 Principles of NSCLC diagnosis and treatment
 
Scientific Directors: Isabelle Schmitt-Opitz and Suresh Senan
 
 Period
 November 2020 / mid-January 2021  
 ECTS  3  
 Assessment  Test (60 multiple-choice questions)  
 Workload
 hours
 90  
 Units

 

30
   - Clinical examination and basic lab tests [Raffaele Califano] 1
 - Bronchoscopy, EBUS, EUS, mediastinoscopy [Kazuhiro Yasufuku] 1
 - Principles of standard radiologic evaluation including CT-guided biopsy and PET-CT imaging
   [Emile Comans]
1
 - Comorbidity assessment, comprehensive geriatric assessment [Lizza Hendriks] 1
 - Differential diagnosis of other common thoracic malignancies [Kostas Papagiannopoulos] 1
 - Pathology classification & TNM staging [Sabina Berezowska] 1
 - Prognostic and predictive factors [Martin Filipits] 1
 - Evaluation of treatment results: Follow-up workout, response criteria, RECIST [TBC] 1
 - Principles of multidisciplinary treatment [TBC] 1
 - Pre-operative risk assessment [Alessandro Brunelli] 1
 - Surgical treatment of early stage NSCLC [Isabelle Schmitt-Opitz] 1
 - Stereotactic body radiotherapy for stage I NSCLC [Nicolaus Andratschke] 1
 - Adjuvant chemotherapy in N positive disease [Francesco Grossi] 1
 - Treatment of N2 disease: Surgical treatment [Walter Weder] 1
 - Treatment of N2 disease: Neo-adjuvant systemic therapy [Pilar Garrido] 1
 - Treatment of locally advanced NSCLC [Matthias Guckenberger] 2
 - Surgical treatment of T4 tumours [TBC] 1
 - Multimodality treatment of sulcus superior tumours [TBC] 1
 - Chemotherapy for advanced disease [Rolf Stahel] 2
 - Targeted therapy for advanced disease: EGFR [Christian Britschgi] 2
 - Targeted therapy for advanced disease: ALK and others [Oliver Gautschi] 2
 - Immunotherapy for advanced disease [Alessandra Curioni] 2
- Combination partners for immunotherapy: chemotherapy, radiotherapy [Alessandra Curioni]  
 - Oligo-metastases & oligo-progression [Nicolaus Andratschke] 1
 - Bone modifying agents [Sarah Danson] 1
  
 Module 4

 Principles of treatment: SCLC, MPM, thymoma & thymic cancer
 
Scientific Directors: Alessandra Curioni and Martin Früh

 
 Period  Mid January / March 2021  
 ECTS
 3  
 Assessment
 Test (60 multiple-choice questions)  
 Workload
 hours
 90  
 Units

 

30
   - SCLC: Pathology, staging and prognostic factors for SCLC [Alexander Soltermann] 1
 - SCLC: Management of very early disease with local treatment [Alexandros Papachristofilou] 1
 - SCLC: Multi-modality treatment of LD SCLC [Dirk de Ruysscher] 2
 - SCLC: Multi-modality treatment of ED SCLC [Martin Früh] 2
 - MPM: Pathology, staging and prognostic factors [Paul Baas] 1
 - MPM: Multimodality treatment with curative intend [Isabelle Schmitt-Opitz] 2
 - MPM: Systemic treatment of unresectable disease [Alessandra Curioni] 2
 - Thymoma & thymic cancer: Pathology, staging and prognostic factors [Alexander Tzankov] 1
 - Thymoma & thymic cancer: Surgery and multimodality concepts [Walter Weder] 2
 - Thymoma & thymic cancer: Systemic treatment [Nicholas Girard] 2
 - Rare thoracic cancer: Trachea [Daniel Franzen] 1
 - Rare thoracic cancer: Neuroendocrine tumours [Aurel Perren] 2
 - Oligo-metastatic lung disease: Surgical resection [Walter Weder] 1
 - Oligo-metastatic lung disease: SBRT [Dirk de Ruysscher] 1
 - Supportive therapy to systemic therapy [Markus Jörger] 2
 - Palliative therapy: Dyspnoea [Daniel Franzen] 2
 - Treatment of CNS metastases [Nikolas Andratschke] 2
 - Psycho-social interventions [Luzia Travado] 2
 - Guidelines ESMO, NCCN, ASCO [TBC] 1
  
 Seminar 3
 CAS Lung Cancer programme, to include visits labs and clinical activities  
 Date and
 place
 May 2021, University of Zurich  
 ECTS  1  
 Assessment  By the chairs’ evaluation of the clinical case presentation  
 Workload
 hours
  30
  Programme to be announced  

 




 

Follow us